MediumCardiologyHeart failure with reduced ejection fractionau-amcau-racp
A 69-year-old man with ischaemic cardiomyopathy (LVEF 30% on echocardiogram) presents to clinic for optimisation of chronic heart failure management. He is euvolaemic, NYHA class II, blood pressure 118/70 mmHg and heart rate 72 bpm in sinus rhythm. Which combination of medicines represents the current recommended foundational therapy for heart failure with reduced ejection fraction according to Australian guidelines, assuming no contraindications?